Search for a report

ASIA PACIFIC STEM CELL MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • ASIA PACIFIC STEM CELL MARKET FORECAST 2021-2028

ASIA PACIFIC STEM CELL MARKET FORECAST 2021-2028

The Asia Pacific stem cell market is expected to register a CAGR of 8.42%, over the forecast period of 2021 to 2028. The region’s market growth is attributed to factors such as the increased incidence of chronic diseases, the developing economic stability, and the rising medical tourism in emerging countries like China and India. The Asia Pacific stem cell market growth is assessed by evaluating China, Japan, India, Thailand, Australia & New Zealand, South Korea, Vietnam, Indonesia, and the rest of the Asia Pacific.

ASIA PACIFIC STEM CELL MARKET FORECAST 2021-2028

Asia Pacific Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries and Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) by Product (Adult Stem Cell (Hematopoietic Stem Cell, Neural Stem, Umbilical Cord Stem Cell, Mesenchymal Stem Cell, Dental Stem Cell), Human Embryonic Stem Cell, Pluripotent, Mouse/rat Neural) by Technology (Acquisition (Stem Cell Bone Marrow Market, Stem Cell Apheresis, Stem Cell Umbilical Cord), Cryopreservation, Expansion and Sub-culture, Production (Stem Cell Culture, Therapeutic Cloning, Ivf)) by Application (Regenerative Medicine, Drug Discovery and Development) by Treatment Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy) and by Geography.

Request free sample

The Asia Pacific stem cell market is expected to register a CAGR of 8.42%, over the forecast period of 2021 to 2028. The region’s market growth is attributed to factors such as the increased incidence of chronic diseases, the developing economic stability, and the rising medical tourism in emerging countries like China and India.
asia-pacific-stem-cell-market-trends

To learn more about this report, request a free sample copy

The Asia Pacific stem cell market growth is assessed by evaluating China, Japan, India, Thailand, Australia & New Zealand, South Korea, Vietnam, Indonesia, and the rest of the Asia Pacific. China’s stem cell market is observing a considerable growth, and this is primarily accredited to the government’s rising involvement in reinforcing the country’s biotech sector. For instance, in 2019, China’s government dedicated $18 billion to technology research, in its most recent five-year plan. Moreover, the current expansions and modernizations, in terms of the country’s healthcare infrastructure, the rising private and public initiatives to use stem cell treatment, and the presence of a supportive regulatory directive for stem cell research, further contribute to China’s market growth.

Conversely, the surging demand for regenerative treatment options essentially drives the stem cell market in India. The growing awareness among the masses, regarding the importance of stem cell therapies, especially concerning the treatment of incurable conditions, and the supportive government initiatives, also play a significant role. As a result, these factors are anticipated to propel the Asia Pacific stem cell market growth, over the forecast period.

Thermo Fisher Scientific, headquartered in the United States, holds the leading position in serving science, catering to over 400,000 customers worldwide. The company operates through four business segments, namely, analytical instruments, laboratory products and services, specialty diagnostics, and life science solutions.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      •    KEY DRIVERS
        • SURGING DEMAND OF STEM CELLS IN REGENERATIVE MEDICINE
        • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES AND RESEARCH
        • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
        • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
        • TECHNOLOGICAL ADVANCEMENTS
      •    KEY RESTRAINTS
        • STRINGENT GOVERNMENT REGULATIONS
        • HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
        • ETHICAL ISSUES AND SOCIAL COMPLEXITIES ASSOCIATED WITH STEM CELLS
        • LESS RESPONSIVENESS IN THE DEVELOPED ECONOMIES
    1. KEY ANALYTICS
      •    PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYER’S POWER
        • SUPPLIER’S POWER
        • COMPETITIVE RIVALRY
      • IMPACT OF COVID-19 ON STEM CELL MARKET
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
      • HISTORY OF STEM CELL
      • REGULATORY FRAMEWORK
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • KEY INVESTMENT INSIGHTS
    2. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    3. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    4. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY
    3. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA PACIFIC
    1. COMPETITIVE LANDSCAPE
      •    KEY STRATEGIC DEVELOPMENTS
        • MERGER & ACQUISITIONS
        • PRODUCT LAUNCH & DEVELOPMENTS
        • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
        • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
      •    COMPANY PROFILE
        • ALLCELLS LLC
        • BECTON, DICKINSON AND COMPANY (BD)
        • CORNING INC
        • CYTORI THERAPEUTICS
        • GE HEALTHCARE
        • INTERNATIONAL STEM CELL CORP
        • MERCK KGAA (SIGMA ALDRICH)
        • MILTENYI BIOTEC
        • PLURISTEM THERAPEUTICS INC
        • QIAGEN NV
        • SMITH & NEPHEW PLC
        • STEMCELL TECHNOLOGIES
        • STRYKER CORPORATION
        • TAKARA HOLDINGS INC
        • THERMO FISHER SCIENTIFIC INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – STEM CELL

    TABLE 2: ASIA PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: ASIA PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: ASIA PACIFIC STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: ASIA PACIFIC STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: ASIA PACIFIC ADULT STEM CELL MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: ASIA PACIFIC ADULT STEM CELL MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: ASIA PACIFIC STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: ASIA PACIFIC STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: ASIA PACIFIC ACQUISITION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: ASIA PACIFIC ACQUISITION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: ASIA PACIFIC PRODUCTION MARKET, BY TYPES, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: ASIA PACIFIC PRODUCTION MARKET, BY TYPES, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: ASIA PACIFIC STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: ASIA PACIFIC STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: ASIA PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: ASIA PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 19: ASIA PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 20: LEADING PLAYERS OPERATING IN ASIA PACIFIC STEM CELL MARKET

    FIGURES LIST

    FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 2: OPPORTUNITY MATRIX

    FIGURE 3: VENDOR LANDSCAPE

    FIGURE 4: KEY INVESTMENT INSIGHTS

    FIGURE 5: ASIA PACIFIC STEM CELL MARKET, BY THERAPEUTIC APPLICATION, IN 2020

    FIGURE 6: ASIA PACIFIC STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 7: ASIA PACIFIC STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)

    FIGURE 8: ASIA PACIFIC STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 9: ASIA PACIFIC STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 10: ASIA PACIFIC STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 11: ASIA PACIFIC STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)

    FIGURE 12: ASIA PACIFIC STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 13: ASIA PACIFIC STEM CELL MARKET, BY PRODUCT, IN 2020

    FIGURE 14: ASIA PACIFIC STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 15: ASIA PACIFIC STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 16: ASIA PACIFIC STEM CELL MARKET, BY NEURAL STEM, 2021-2028 (IN $ MILLION)

    FIGURE 17: ASIA PACIFIC STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 18: ASIA PACIFIC STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 19: ASIA PACIFIC STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 20: ASIA PACIFIC STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)

    FIGURE 21: ASIA PACIFIC STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)

    FIGURE 22: ASIA PACIFIC STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)

    FIGURE 23: ASIA PACIFIC STEM CELL MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 24: ASIA PACIFIC STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)

    FIGURE 25: ASIA PACIFIC STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: ASIA PACIFIC STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)

    FIGURE 27: ASIA PACIFIC STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)

    FIGURE 28: ASIA PACIFIC STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)

    FIGURE 29: ASIA PACIFIC STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 30: ASIA PACIFIC STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)

    FIGURE 31: ASIA PACIFIC STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)

    FIGURE 32: ASIA PACIFIC STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)

    FIGURE 33: ASIA PACIFIC STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)

    FIGURE 34: ASIA PACIFIC STEM CELL MARKET, BY APPLICATION, IN 2020

    FIGURE 35: ASIA PACIFIC STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)

    FIGURE 36: ASIA PACIFIC STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

    FIGURE 37: ASIA PACIFIC STEM CELL MARKET, BY TREATMENT TYPE, IN 2020

    FIGURE 38: ASIA PACIFIC STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 39: ASIA PACIFIC STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 40: ASIA PACIFIC STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 41: ASIA PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 42: CHINA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: JAPAN STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 44: INDIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 45: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 46: SOUTH KOREA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 47: THAILAND STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: INDONESIA STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: VIETNAM STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 50: REST OF ASIA PACIFIC STEM CELL MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        •    COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • THAILAND
          • INDONESIA
          • VIETNAM
          • REST OF ASIA PACIFIC
    1. MARKET BY THERAPEUTIC APPLICATION
      • ORTHOPEDIC TREATMENTS
      • INJURIES AND WOUNDS
      • ONCOLOGY DISORDERS
      • CARDIOVASCULAR DISORDERS
      • NEUROLOGICAL DISORDERS
      • DIABETES
      • OTHER THERAPEUTIC APPLICATIONS
    2. MARKET BY PRODUCT
      •    ADULT STEM CELL
        • HEMATOPOIETIC STEM CELL
        • NEURAL STEM
        • UMBILICAL CORD STEM CELL
        • MESENCHYMAL STEM CELL
        • DENTAL STEM CELL
      • HUMAN EMBRYONIC STEM CELL
      • PLURIPOTENT
      • MOUSE/RAT NEURAL
    3. MARKET BY TECHNOLOGY
      •    ACQUISITION
        • STEM CELL BONE MARROW MARKET
        • STEM CELL APHERESIS
        • STEM CELL UMBILICAL CORD
      • CRYOPRESERVATION
      • EXPANSION AND SUB-CULTURE
      •    PRODUCTION
        • STEM CELL CULTURE
        • THERAPEUTIC CLONING
        • IVF
    1. MARKET BY APPLICATION
      • REGENERATIVE MEDICINE
      • DRUG DISCOVERY AND DEVELOPMENT
    2. MARKET BY TREATMENT TYPE
      • ALLOGENEIC STEM CELL THERAPY
      • AUTOLOGIC STEM CELL THERAPY
      • SYNGENEIC STEM CELL THERAPY

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now